Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 33827139

Brentuximab vedotin in combination with nivolumab in relapsed or refractory Hodgkin lymphoma: 3-year study results.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Blood
Publication date
2021 Aug 12
First author
Advani RH

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Blood. 2021 Aug 12;138(6):421-422. doi: 10.1182/blood.2021011774.
    note
    Source null
    related pmid
    34383039
    relationship
    Comment in

Authors and identifiers

  1. name
    Advani RH
    type
    Author
  2. name
    Moskowitz AJ
    type
    Author
  3. name
    Bartlett NL
    type
    Author
  4. name
    Vose JM
    type
    Author
  5. name
    Ramchandren R
    type
    Author
  6. name
    Feldman TA
    type
    Author
  7. name
    LaCasce AS
    type
    Author
  8. name
    Christian BA
    type
    Author
  9. name
    Ansell SM
    type
    Author
  10. name
    Moskowitz CH
    type
    Author
  11. name
    Brown L
    type
    Author
  12. name
    Zhang C
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Advani RH
    type
    Author
  2. name
    Moskowitz AJ
    type
    Author
  3. name
    Bartlett NL
    type
    Author
  4. name
    Vose JM
    type
    Author
  5. name
    Ramchandren R
    type
    Author
  6. name
    Feldman TA
    type
    Author
  7. name
    LaCasce AS
    type
    Author
  8. name
    Christian BA
    type
    Author
  9. name
    Ansell SM
    type
    Author
  10. name
    Moskowitz CH
    type
    Author
  11. name
    Brown L
    type
    Author
  12. name
    Zhang C
    type
    Author
bibliography ids
  1. nci-bib-54547209f4c9d42c977b0a95
book metadata
content sha256
00e37e668ba63255abb36a312b577aa0396df5e594e35f54ca0b3518dad019bd
document type
citation
dois
  1. 10.1182/blood.2020009178
electronic publication date
display
Source null
precision
missing
year
Source null
evidence scope
bibliographic_metadata_only
id
pubmed:33827139
immutable id
pubmed:33827139@00e37e668ba63255abb36a312b577aa0396df5e594e35f54ca0b3518dad019bd
journal
abbreviation
Blood
issn electronic
1528-0020
issn print
0006-4971
issue
6
name
Blood
nlm unique id
7603509
pages
427-438
volume
138
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Blood. 2021 Aug 12;138(6):421-422. doi: 10.1182/blood.2021011774.
    note
    Source null
    related pmid
    34383039
    relationship
    Comment in
outcomes validated
false
pmid
33827139
provenance
batch id
79f1021053e858d13ff3
provider
NCBI PubMed ESummary
record sha256
cddeedfd07ee4e9f558121101c0e893d93a8d333fdfb27e38634d26d3a86200c
response sha256
671d3d2962f73c698a1cb338d73222e2cc6cfdf61569f91b42612d5b59822e05
retrieved at
2026-09-09T23:47:59.098265+00:00
publication date
display
2021 Aug 12
precision
day
year
2021
publication types
  1. Clinical Trial, Phase I
  2. Clinical Trial, Phase II
  3. Journal Article
  4. Multicenter Study
  5. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/33827139/
title
Brentuximab vedotin in combination with nivolumab in relapsed or refractory Hodgkin lymphoma: 3-year study results.

Preserved source evidence · Not medical advice